Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
“Het voornaamste doel bij post-COVID is symptoomverlichting, vaak niet-medicamenteus”
jun 2026 | Virale infecties